Manufacturing and Facilities eBook
Read the article:
How Integrated Project Delivery Enables Speed: A Phase-By-Phase Guide
Read the eBook:
BioPharm International’s Manufacturing and Facilities 2022 eBook
By eliminating the waste involved in traditional approaches to project set-up and execution, integrated project delivery helps innovators in the European life sciences market meet their fast-track delivery targets.
The European life sciences industry is red hot. The DACH (Germany, Austria, and Switzerland) region alone, attracted nearly 20% of Europe’s biggest life sciences investments last year. With this influx of cash comes the potential for commercial success and for a new generation of advanced, life-saving therapies. To unlock that potential, though, life science innovators need more—more manufacturing capacity, more flexibility, and more expertise to get their products to market faster.
Read the article:
How Integrated Project Delivery Enables Speed: A Phase-By-Phase Guide
Read the eBook:
BioPharm International’s Manufacturing and Facilities 2022 eBook
The key to ‘more’ is sometimes ‘less’: less wasted effort, more value for the project owner; less fragmentation between teams, more shared expertise. These subtle shifts are the key to delivering complex, high-value facilities faster and more cost-effectively. The shifts are not easy to embrace, but they will pay off a hundredfold for teams who successfully make the transition. That means adopting a lean culture and using it to power an integrated project delivery approach.
Read this article in BioPharm International’s November Manufacturing and Facilities 2022 eBook.
Christian Goesker, is managing director, Thomas Lederer, is office lead, director EPCM Projects, and Mike Barrett, is vice president, Project Delivery Services, all at CRB Group.
BioPharm International
eBook: Manufacturing and Facilities
November 2022
Pages: 18–21
When referring to this article, please cite it as C. Goesker, T. Lederer, and M. Barrett, “How Integrated Project Delivery Enables Speed: A Phase-By-Phase Guide,” BioPharm International's Manufacturing and Facilities eBook (November 2022).
EXO Biologics and ExoXpert Reach Two Critical Milestones that Advance Exosomes
December 3rd 2024EXO Biologics and its subsidiary, ExoXpert, have received GMP certification of a European exosomes manufacturing facility and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.